Citation Impact
Citing Papers
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Computerized Automated Reminder Diabetes System (CARDS): E-Mail and SMS Cell Phone Text Messaging Reminders to Support Diabetes Management
2009 Standout
Epidemiology and causes of preterm birth
2008 Standout
Cyclooxygenase Isozymes: The Biology of Prostaglandin Synthesis and Inhibition
2004 Standout
Effects of the antiprogesterone RU 486 on preterm birth in the rat
1987
Embryo Implantation
2000 Standout
Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review
2012 Standout
Can available interventions end preventable deaths in mothers, newborn babies, and stillbirths, and at what cost?
2014 Standout
Cushing's syndrome
2015 Standout
Management of Gestational Diabetes: Pharmacologic Treatment Options and Glycemic Control
2006
Rethinking mechanisms, diagnosis and management of endometriosis
2019 Standout
The effect of contraceptive pills on the measured blood loss in medical termination of pregnancy by mifepristone and misoprostol: a randomized placebo controlled trial
2002
Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone
1991
Insulins and oral hypoglycemic agents in pregnancy
2006
Effects of progesterone antagonist ZK 98.299 on early pregnancy and foetal outcome in bonnet monkeys
1990
A randomized double-blind placebo-controlled study to assess the effect of oral contraceptive pills on the outcome of medical abortion with mifepristone and misoprostol
1999
Platelet Activation and Atherothrombosis
2007 Standout
Pregnancy outcome after exposure to misoprostol in Brazil: a prospective, controlled study
1999 Standout
Mifepristone (RU486) alone or in combination with a prostaglandin analogue for termination of early pregnancy: a review
1991
Mifepristone (RU486): A review
1997
Medical abortion in early pregnancy: A review of the evidence
1997
Cervical ripening in humans: Potential roles of estrogen, progesterone, and insulin-like growth factor-I
1996
Low-potency oestrogen and risk of endometrial cancer: a case-control study
1999
The preterm parturition syndrome
2006 Standout
Expression of cyclo-oxygenase in human endometrium during the implantation period
1999
How were new medicines discovered?
2011 Standout
Risk and prognosis of ovarian cancer in women with endometriosis: a meta-analysis
2014
TAXI/UAS: A Molecular Switch to Control Expression of Genes In Vivo
1996 StandoutNobel
Insulin, insulin analogues and diabetic retinopathy
2008
11-dehydro thromboxane B2: A reliable parameter of thromboxane A2 production in dogs
1993 StandoutNobel
The impact of hormones on menopausal sexuality: a literature review
2004
A Study of Sexuality and Health among Older Adults in the United States
2007 Standout
Novel cyclooxygenase‐catalyzed bioactive prostaglandin F2α from physiology to new principles in inflammation
2006
Endometriosis: pathogenesis and treatment
2013 Standout
Endometriosis and ovarian cancer: potential benefits and harms of screening and risk-reducing surgery
2015
ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria
2011 Standout
The Human Myometrium as a Target for Melatonin
2003
Unraveling the two entities of endometrioid ovarian cancer: A single center clinical experience
2012
Mechanisms of implantation: strategies for successful pregnancy
2012 Standout
Current literature in diabetes
2001
Long-lived enzymatic metabolites of thromboxane B2 in the human circulation
1986
Circulating and urinary thromboxane B2 metabolites in the rabbit: 11-dehydro-thromboxane B2 as parameter of thromboxane production
1986
Regulation of Parturition Update: Endocrine and Paracrine Effectors of Term and Preterm Labor
1998
Maternal Glycemic Control and Hypoglycemia in Type 1 Diabetic Pregnancy
2007
Endocrine and Paracrine Regulation of Birth at Term and Preterm*
2000 Standout
The Science behind 25 Years of Ovarian Stimulation for in Vitro Fertilization
2006
Evaluating non-randomised intervention studies
2003 Standout
Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease.
1983
Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review.
2006
The Steroid Hormone Antagonist RU486: Mechanism at the Cellular Level and Clinical Applications
1991
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
U.S. Medical Eligibility Criteria for Contraceptive Use, 2016
2016 Standout
Contragestion and Other Clinical Applications of RU 486, an Antiprogesterone at the Receptor
1989 Science
Endometriosis
2020 Standout
Mechanisms of Diabetic Complications
2013 Standout
Leukemia Inhibitory Factor in Human Reproduction
1998
Pluripotency and nuclear reprogramming
2008 StandoutNobel
Extrapineal melatonin: sources, regulation, and potential functions
2014 Standout
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
Prostaglandins and Inflammation
2011 Standout
Leukemia-Inhibitory Factor—Neuroimmune Modulator of Endocrine Function*
2000
Risk factors and interventions related to maternal and pre-pregnancy obesity, pre-diabetes and diabetes for maternal, fetal and neonatal outcomes: a systematic review
2013
Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities.
1995 Standout
Works of M.L. Swahn being referenced
Hormonal and surgical treatments for endometriosis and risk of epithelial ovarian cancer
2013
Endometriosis as a prognostic factor for cancer survival
2010
Early luteal phase treatment with mifepristone (RU 486) for fertility regulation
1993
Termination of early human pregnancy with RU 486 (mifepristone) and the prostaglandin analogue sulprostone: a multi-centre, randomized comparison between two treatment regimens
1989
Oral administration of RU 486 and 9-methylene PGE2 for termination of early pregnancy
1990
The effect of RU486 administered during the proliferative and secretory phase of the cycle on the bleeding pattern, hormonal parameters and the endometrium
1988
Insulin lispro therapy in pregnancies complicated by type 1 diabetes mellitus
2002
Mode of Action of RU 486
1993
The effect of various doses of mifepristone on endometrial leukaemia inhibitory factor expression in the midluteal phase--an immunohistochemical study
1997
Effect of oral prostaglandin E2 on uterine contractility and outcome of treatment in women receiving RU 486 (mifepristone) for termination of early pregnancy
1989
Replens versus dienoestrol cream in the symptomatic treatment of vaginal atrophy in postmenopausal women
1996
Profiles of prostaglandin metabolites in the human circulation
1982
Termination of pregnancy with reduced doses of mifepristone
1994
Termination of very early pregnancy by RU 486 — An antiprogestational compound
1984
Plasma levels of antiprogestin RU 486 following oral administration to non-pregnant and early pregnant women
1986
Diurnal variation of uterine contractility
1984